DK0777649T3 - N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamider som kappareceptorantagonister - Google Patents
N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamider som kappareceptorantagonisterInfo
- Publication number
- DK0777649T3 DK0777649T3 DK95917437T DK95917437T DK0777649T3 DK 0777649 T3 DK0777649 T3 DK 0777649T3 DK 95917437 T DK95917437 T DK 95917437T DK 95917437 T DK95917437 T DK 95917437T DK 0777649 T3 DK0777649 T3 DK 0777649T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- unsubstituted
- kappar
- acetamides
- phenylethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1994/001399 WO1996006078A1 (fr) | 1994-08-24 | 1994-08-24 | N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides utilises en tant qu'antagonistes du recepteur kappa |
| PCT/IB1995/000374 WO1996006077A1 (fr) | 1994-08-24 | 1995-05-18 | N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamides utilises en tant qu'antagonistes des recepteurs kappa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0777649T3 true DK0777649T3 (da) | 1999-11-29 |
Family
ID=14098616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95917437T DK0777649T3 (da) | 1994-08-24 | 1995-05-18 | N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamider som kappareceptorantagonister |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5837720A (fr) |
| EP (1) | EP0777649B1 (fr) |
| JP (1) | JP2935899B2 (fr) |
| AT (1) | ATE182138T1 (fr) |
| AU (1) | AU2350695A (fr) |
| BR (1) | BR9503775A (fr) |
| CA (1) | CA2196885C (fr) |
| CO (1) | CO4410322A1 (fr) |
| DE (1) | DE69510802T2 (fr) |
| DK (1) | DK0777649T3 (fr) |
| ES (1) | ES2133767T3 (fr) |
| FI (1) | FI116056B (fr) |
| GR (1) | GR3031133T3 (fr) |
| IL (1) | IL114969A0 (fr) |
| MX (1) | MX9701367A (fr) |
| TR (1) | TR199501055A2 (fr) |
| WO (2) | WO1996006078A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6133307A (en) * | 1997-04-30 | 2000-10-17 | Warner-Lambert Company | Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists |
| US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| WO1999003459A1 (fr) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Compositions pharmaceutiques anti-pruritiques contenant des agonistes de recepteurs kappa et procede de traitement du prurit a l'aide desdites compositions |
| US6284769B1 (en) | 1999-12-03 | 2001-09-04 | The Board Of Trustees Of The University Of Illinois | Nonpeptide kappa opioid receptor antagonists |
| WO2014148574A1 (fr) * | 2013-03-22 | 2014-09-25 | 参天製薬株式会社 | Inhibition de la production d'il-2 |
| JP6577943B2 (ja) * | 2013-06-28 | 2019-09-18 | ネクター セラピューティクス | κオピオイド作動薬及びその使用 |
| AU2015212306A1 (en) * | 2014-01-24 | 2016-07-21 | Cadila Healthcare Limited | Novel heterobicyclic compounds as Kappa opioid agonists |
| EP3291813A4 (fr) | 2015-05-06 | 2019-01-02 | The Regents of The University of California | Modulateurs de k-ras |
| US11358940B2 (en) | 2017-04-20 | 2022-06-14 | The Regents Of The University Of California | K-Ras modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4034785A1 (de) * | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1994
- 1994-08-24 WO PCT/JP1994/001399 patent/WO1996006078A1/fr unknown
-
1995
- 1995-05-18 DK DK95917437T patent/DK0777649T3/da active
- 1995-05-18 JP JP7529926A patent/JP2935899B2/ja not_active Expired - Fee Related
- 1995-05-18 WO PCT/IB1995/000374 patent/WO1996006077A1/fr active IP Right Grant
- 1995-05-18 AT AT95917437T patent/ATE182138T1/de not_active IP Right Cessation
- 1995-05-18 AU AU23506/95A patent/AU2350695A/en not_active Abandoned
- 1995-05-18 EP EP95917437A patent/EP0777649B1/fr not_active Expired - Lifetime
- 1995-05-18 ES ES95917437T patent/ES2133767T3/es not_active Expired - Lifetime
- 1995-05-18 US US08/793,225 patent/US5837720A/en not_active Expired - Fee Related
- 1995-05-18 CA CA002196885A patent/CA2196885C/fr not_active Expired - Fee Related
- 1995-05-18 MX MX9701367A patent/MX9701367A/es not_active IP Right Cessation
- 1995-05-18 DE DE69510802T patent/DE69510802T2/de not_active Expired - Fee Related
- 1995-08-17 IL IL11496995A patent/IL114969A0/xx unknown
- 1995-08-23 BR BR9503775A patent/BR9503775A/pt not_active IP Right Cessation
- 1995-08-23 CO CO95037814A patent/CO4410322A1/es unknown
- 1995-08-24 TR TR95/01055A patent/TR199501055A2/xx unknown
-
1997
- 1997-02-21 FI FI970746A patent/FI116056B/fi not_active IP Right Cessation
-
1999
- 1999-09-01 GR GR990402218T patent/GR3031133T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI970746A0 (fi) | 1997-02-21 |
| DE69510802T2 (de) | 1999-11-04 |
| ATE182138T1 (de) | 1999-07-15 |
| AU2350695A (en) | 1996-03-14 |
| JP2935899B2 (ja) | 1999-08-16 |
| CA2196885A1 (fr) | 1996-02-29 |
| DE69510802D1 (de) | 1999-08-19 |
| TR199501055A2 (tr) | 1996-07-21 |
| JPH09510731A (ja) | 1997-10-28 |
| CA2196885C (fr) | 2001-01-23 |
| EP0777649A1 (fr) | 1997-06-11 |
| FI116056B (fi) | 2005-09-15 |
| FI970746A (fi) | 1997-02-21 |
| BR9503775A (pt) | 1996-04-16 |
| IL114969A0 (en) | 1995-12-08 |
| EP0777649B1 (fr) | 1999-07-14 |
| WO1996006078A1 (fr) | 1996-02-29 |
| ES2133767T3 (es) | 1999-09-16 |
| US5837720A (en) | 1998-11-17 |
| MX9701367A (es) | 1997-05-31 |
| WO1996006077A1 (fr) | 1996-02-29 |
| GR3031133T3 (en) | 1999-12-31 |
| CO4410322A1 (es) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0777649T3 (da) | N-[2-(pyrrolidinyl-1)-1-phenylethyl]acetamider som kappareceptorantagonister | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| DE69705829D1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| JP2004530656A5 (fr) | ||
| AU2432002A (en) | 3-substituted oxindole beta 3 agonists | |
| JO2239B1 (en) | Method for preparing benzothophen derivatives | |
| TW200716572A (en) | Peroxisome proliferator activated receptor alpha agonists | |
| EA200400943A1 (ru) | Тиазольные и оксазольные производные, которые модулируют ppar активность | |
| EA200300183A1 (ru) | Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции | |
| EA200000023A1 (ru) | Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола | |
| HUP0300298A2 (hu) | 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| RU2307829C2 (ru) | Карбоксамидные производные амидного типа | |
| RS50109B (sr) | Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil-piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora | |
| DE60016786D1 (de) | Bicyclische vasopressin-agoniste | |
| ES2104370T3 (es) | Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion. | |
| EP0976404A3 (fr) | Compositions pharmaceutiques pour la prévention et la therapie de troubles cognitifes chez les mammifères | |
| KR880008999A (ko) | 3-아릴-5-알킬티오-4h-1,2,4-트리아졸 | |
| ATE248163T1 (de) | Neuartige, pharmazeutisch aktive verbindung | |
| EP1172106A3 (fr) | Utilisation de derives fluoroalkoxybenzylamino d'heterocycles contenant de l'azote comme antagonistes de la substance p | |
| EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
| ATE318800T1 (de) | Indolderivate als mcp-1 rezeptor antagonisten | |
| RS50449B (sr) | Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija | |
| ATE101599T1 (de) | Muscarin-rezeptor-antagonisten. | |
| KR940005581A (ko) | 안지오텐신 ii 길항물질 | |
| GR3035703T3 (en) | Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system |